![Lou Apicella](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Michael V. Mullen | M | - |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | 9 Jahre |
Scott Rezek | M | - |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
Robert P. Gasparini | M | 70 |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | 2 Jahre |
Daniel Bibb Coleman | M | 59 |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
Richard B. Lanman | M | 69 |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | 3 Jahre |
James E. Cantrell | M | - |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
Stephen Eck | M | 69 |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
Daniel Coleman | M | - |
CirculoGene Theranostics, Inc.
![]() CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 8 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Lou Apicella
- Persönliches Netzwerk